Small Molecule Cancer Drugs Market Overall Study Report 2022-2028 | Otsuka Pharmaceutical Co. Ltd, Eli Lilly and Co
Small molecule cancer
drugs is in the very early stages of development for use in the treatment of
cancer. In recent years, it has been found that cancer cells secrete chemicals
as a defense against cancer treatments. These chemicals can be detected by the
body's immune system, and these chemicals are often found within tumors. The
body's immune system recognizes some cancer cells as foreign particles that may
be harmful to the body.
With
growing cancer burden worldwide, key pharmaceutical and biotechnology companies
are focused on developing novel therapies and medications for the treatment of
different types of cancer. With growing focus on small molecule cancer drugs,
research and development activities are likely to surge in the near future.
Hence, such factors can augment growth small molecule cancer drugs market in
the near future. Recently, in November 2020, Genesis Therapeutics collaborated
with Genentech for AI-driven multi-target drug discovery.
Comments
Post a Comment